| Mutational landscape and clonal architecture in grade II and III gliomas H Suzuki, K Aoki, K Chiba, Y Sato, Y Shiozawa, Y Shiraishi, T Shimamura, ... Nature genetics 47 (5), 458-468, 2015 | 864 | 2015 |
| Integrated molecular analysis of adult T cell leukemia/lymphoma K Kataoka, Y Nagata, A Kitanaka, Y Shiraishi, T Shimamura, J Yasunaga, ... Nature genetics 47 (11), 1304-1315, 2015 | 804 | 2015 |
| Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers K Kataoka, Y Shiraishi, Y Takeda, S Sakata, M Matsumoto, S Nagano, ... Nature 534 (7607), 402-406, 2016 | 651 | 2016 |
| Somatic mutations and clonal hematopoiesis in aplastic anemia T Yoshizato, B Dumitriu, K Hosokawa, H Makishima, K Yoshida, ... New England Journal of Medicine 373 (1), 35-47, 2015 | 640 | 2015 |
| Age-related remodelling of oesophageal epithelia by mutated cancer drivers A Yokoyama, N Kakiuchi, T Yoshizato, Y Nannya, H Suzuki, Y Takeuchi, ... Nature 565 (7739), 312-317, 2019 | 526 | 2019 |
| Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation T Yoshizato, Y Nannya, Y Atsuta, Y Shiozawa, Y Iijima-Yamashita, ... Blood, The Journal of the American Society of Hematology 129 (17), 2347-2358, 2017 | 306 | 2017 |
| Prognostic relevance of genetic alterations in diffuse lower-grade gliomas K Aoki, H Nakamura, H Suzuki, K Matsuo, K Kataoka, T Shimamura, ... Neuro-oncology 20 (1), 66-77, 2018 | 254 | 2018 |
| Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity Y Kagoya, A Yoshimi, K Kataoka, M Nakagawa, K Kumano, S Arai, ... The Journal of clinical investigation 124 (2), 528-542, 2014 | 233 | 2014 |
| Recurrent somatic mutations underlie corticotropin-independent Cushing’s syndrome Y Sato, S Maekawa, R Ishii, M Sanada, T Morikawa, Y Shiraishi, ... Science 344 (6186), 917-920, 2014 | 205 | 2014 |
| Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity K Kataoka, T Sato, A Yoshimi, S Goyama, T Tsuruta, H Kobayashi, ... Journal of Experimental Medicine 208 (12), 2403-2416, 2011 | 195 | 2011 |
| Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis N Kakiuchi, K Yoshida, M Uchino, T Kihara, K Akaki, Y Inoue, K Kawada, ... Nature 577 (7789), 260-265, 2020 | 184 | 2020 |
| Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer E Sugiyama, Y Togashi, Y Takeuchi, S Shinya, Y Tada, K Kataoka, ... Science immunology 5 (43), eaav3937, 2020 | 181 | 2020 |
| Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling Y Watatani, Y Sato, H Miyoshi, K Sakamoto, K Nishida, Y Gion, Y Nagata, ... Leukemia 33 (12), 2867-2883, 2019 | 180 | 2019 |
| Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia Y Shiozawa, L Malcovati, A Gallì, A Sato-Otsubo, K Kataoka, Y Sato, ... Nature communications 9 (1), 3649, 2018 | 166 | 2018 |
| Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation K Kataoka, Y Nannya, A Hangaishi, Y Imai, S Chiba, T Takahashi, ... Biology of Blood and Marrow Transplantation 15 (2), 195-204, 2009 | 153 | 2009 |
| Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma K Kataoka, M Iwanaga, J Yasunaga, Y Nagata, A Kitanaka, T Kameda, ... Blood, The Journal of the American Society of Hematology 131 (2), 215-225, 2018 | 134 | 2018 |
| Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia M Seki, S Kimura, T Isobe, K Yoshida, H Ueno, Y Nakajima-Takagi, ... Nature genetics 49 (8), 1274-1281, 2017 | 133 | 2017 |
| Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas K Kataoka, H Miyoshi, S Sakata, A Dobashi, L Couronné, Y Kogure, ... Leukemia 33 (7), 1687-1699, 2019 | 126 | 2019 |
| A TLR3-specific adjuvant relieves innate resistance to PD-L1 blockade without cytokine toxicity in tumor vaccine immunotherapy Y Takeda, K Kataoka, J Yamagishi, S Ogawa, T Seya, M Matsumoto Cell reports 19 (9), 1874-1887, 2017 | 114 | 2017 |
| Regeneration of CD8αβ T cells from T-cell–derived iPSC imparts potent tumor antigen-specific cytotoxicity T Maeda, S Nagano, H Ichise, K Kataoka, D Yamada, S Ogawa, H Koseki, ... Cancer research 76 (23), 6839-6850, 2016 | 114 | 2016 |
Seishi OgawaVerified email at umin.ac.jp
